Announced Fri, 19 Jun · 11:37 IST
Trading Window Closure Ahead of Q1 FY27 Results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.9%1-day move
₹30.55
prior close
₹29.99
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-2.2-2.2+5.0-1.9+12.9+35.5+38.2+33.2+20.2+10.8+4.2——
Up moveDown movePending
AI summary
ANG Lifesciences India has closed its trading window from 1 July 2026 until 48 hours after it declares unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended 30 June 2026). The closure applies to insiders, designated persons, and their immediate relatives, per SEBI insider trading regulations. The board meeting date for the results will be announced separately. This is a routine compliance step before quarterly results.
Likely market impact
Routine regulatory compliance, no impact for general investors. Watch for the Q1 FY27 results date, which will reopen the window.